Albuterol for kids
Pro Research Analysisby 
Searched over 200M research papers
Albuterol for Kids: Efficacy, Safety, and Administration Methods
Introduction to Albuterol in Pediatric Asthma Treatment
Albuterol, a beta 2-adrenergic agonist, is widely used to manage asthma in children. It helps in bronchodilation, easing breathing during asthma attacks. This article synthesizes research on the efficacy, safety, and various administration methods of albuterol for children.
Efficacy of Albuterol in Children with Asthma
Oral Albuterol
Studies have shown that oral albuterol is effective in treating childhood asthma. A study involving 20 children aged 6 to 14 years found that a 4 mg dose of albuterol syrup administered four times a day significantly improved pulmonary function compared to placebo, with the syrup formulation being more effective than tablets 1. Another study confirmed the efficacy of albuterol syrup in younger children (3 to 6 years), showing significant improvements in symptom scores and lung function 7.
Extended-Release Albuterol
Extended-release albuterol tablets have also been evaluated for children aged 6 to 12 years. A study involving 157 patients demonstrated that extended-release albuterol significantly improved pulmonary function and reduced asthma symptoms compared to placebo, with no serious adverse events reported 2.
Inhaled Albuterol
Inhaled albuterol, either as an aerosol or dry powder, has been shown to be effective in children aged 4 to 12 years. Both forms provided effective bronchodilation with minimal adverse effects, and a significant number of children preferred the dry powder form 3. Additionally, high-dose nebulized albuterol was found to be more effective than low-dose in improving lung function in children with severe acute asthma 59.
Safety and Tolerance of Albuterol in Children
Side Effects
While albuterol is generally well-tolerated, some side effects have been noted. Common side effects include increased heart rate, tremors, and hyperactivity, but these are usually mild and clinically insignificant 17. High-dose albuterol therapy, whether administered via nebulizer or metered-dose inhaler with a spacer, did not show a significant increase in adverse effects compared to standard doses 5910.
Safety in Young Children
For children younger than 2 years, nebulized albuterol has been shown to improve clinical status during acute asthma episodes without significant adverse effects on arterial oxygen saturation 4. This suggests that nebulized albuterol is a safe option for very young children experiencing acute asthma.
Administration Methods of Albuterol
Nebulization vs. Metered-Dose Inhaler
Nebulization is a common method for administering albuterol in hospital settings. However, recent studies suggest that using a metered-dose inhaler with a spacer device is equally effective and more convenient. A study comparing these two methods in children aged 12 to 60 months found no significant difference in efficacy, with parents reporting easier administration and better acceptance of the spacer device 10.
Premedication for Surgical Procedures
Albuterol has also been used as a premedication to reduce perioperative respiratory adverse events in children undergoing tonsillectomy. A study involving 484 children found that premedication with albuterol significantly reduced the incidence of respiratory complications compared to placebo 6.
Conclusion
Albuterol is a versatile and effective treatment for pediatric asthma, with various administration methods tailored to different age groups and clinical settings. Oral, extended-release, and inhaled forms of albuterol have all demonstrated significant efficacy in improving lung function and reducing asthma symptoms in children. While generally safe, monitoring for mild side effects is recommended. The choice of administration method can be guided by the child's age, preference, and specific clinical scenario, with both nebulization and metered-dose inhalers being viable options.
Sources and full results
Most relevant research papers on this topic
Oral albuterol in the treatment of childhood asthma.
Four milligrams of albuterol syrup (2 mg/5 ml) four times a day is the preferred dose for asthmatic children aged 6 to 14 years, with syrup providing longer-lasting relief and greater heart rate changes.
RCTExtended-release albuterol in the treatment of 6- to 12-year-old asthmatic children.
Extended-release albuterol tablets (4 mg) effectively improved pulmonary function and asthmatic symptoms in children aged 6-12 years, with no serious treatment-related adverse events.
RCTAlbuterol treatment for children with asthma: a comparison of inhaled powder and aerosol.
Albuterol taken four times a day as either aerosol or dry powder is both effective and well-tolerated in children with asthma, with powder being preferred by more children.
RCTControlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma.
Nebulized albuterol shows potential in improving clinical status in children younger than 2 years with acute asthma, warranting further trials.
RCT
Highly CitedHigh-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma.
High-dose, frequently administered nebulized albuterol is safe and effective in treating severe, acute asthma in children, with greater improvement in symptoms and lower hospitalization rates.
RCTHighly CitedEffect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.
Albuterol premedication significantly reduces the risk of perioperative respiratory adverse events in children undergoing tonsillectomy compared to placebo.
RCT
Large Human TrialHighly CitedAlbuterol syrup in the treatment of the young asthmatic child.
Albuterol syrup is effective and safe for treating young asthmatic children, reducing symptom scores and need for additional medications without significant side effects.
RCTPrevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
A single 50-microgram dose of salmeterol powder effectively and safely protects against exercise-induced bronchospasm in asthmatic children for at least 12 hours, providing a significantly longer protection than albuterol.
RCTHigh-Dose Albuterol by Metered-Dose Inhaler Plus a Spacer Device Versus Nebulization in Preschool Children With Recurrent Wheezing: A Double-Blind, Randomized Equivalence Trial
Albuterol administered through a spacer device is as effective as nebulizer for treating acute wheezing in preschool children, making it an easier and more cost-effective alternative.
RCTHighly Cited